Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study

In a comparative oncology study with progression-free or overall survival as the endpoint, the primary or key secondary analysis is routinely stratified by patients’ baseline characteristics when evaluating the treatment difference. The validity of a conventional strategy such as a stratified HR ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ryan, McCaw, Zachary, Tian, Lu, Uno, Hajime, Hong, Fangxin, Kim, Dae Hyun, Wei, Lee-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606770/
https://www.ncbi.nlm.nih.gov/pubmed/34799398
http://dx.doi.org/10.1136/jitc-2021-003323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606770/
https://www.ncbi.nlm.nih.gov/pubmed/34799398
http://dx.doi.org/10.1136/jitc-2021-003323

Ejemplares similares